“We're going to Consider how the commercialization of the compound fits in with our business product at Adastra in an effort to position ourselves to aid the desire for a secure offer of copyright,” said Main executive officer Michael Forbes inside of a information release. The company instructed VICE News it wouldn't be commenting additional.I